DOCSLIB.ORG

Enprofylline Disposition in the Presence and Absence of Amoxycillin Or Erythromycin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Enprofylline Disposition in the Presence and Absence of Amoxycillin Or Erythromycin Br. J. clin. Pharmac. (1987), 24, 57-61 Enprofylline disposition in the presence and absence of amoxycillin or erythromycin DANIEL S. SITAR1'3 5, FRED Y. AOKI" 23'4'5, DARYL J. HOBAN4, KARL-GUNNAR HIDINGER6, PATRICK R. MONTGOMERY' 3'5 & PAUL A. MITENKO" 3'5 Sections of 'Clinical Pharmacology and 2Infectious Diseases, Departments of 3Medicine, 4Medical Microbiology and 5Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba and 6Astra Pharmaceuticals Canada Ltd, Mississauga, Ontario, Canada 1 The kinetic disposition of a novel xanthine bronchodilator, enprofylline, was deter- mined in young healthy male volunteers in the presence and absence of amoxycillin or erythromycin. These data were compared to those derived from a similar study of theophylline disposition in the presence and absence of erythromycin. 2 Erythromycin inhibited theophylline disposition only in those subjects in whom the control kinetic study was done after antibiotic ingestion, but the effect was modest. Erythromycin had no effect on enprofylline disposition. 3 Amoxycillin reduced the renal clearance of enprofylline, but the change was not statistically significant. Keywords enprofylline erythromycin theophylline amoxycillin drug interactions Introduction Enprofylline, a novel xanthine drug whose enprofylline disposition is affected by concurrent mechanism of action is claimed not to involve antibiotic administration. inhibition of phosphodiesterase, is mainly ex- creted unmetabolized by the kidney (Borga et al., 1983). This is in contrast to theophylline Methods whose elimination is largely dependent on hepatic metabolism (Ogilvie, 1978). It has been reported Thirty-two young, healthy male volunteers par- that theophylline clearance is reduced during ticipated in this study after being informed of concurrent administration of macrolide anti- its nature and purpose and providing signed biotics such as erythromycin and troleandomycin. consent. This investigation was approved by the The duration of therapy appears to be important Faculty Committee on the Use of Human Sub- to demonstrate the interaction (Weinberger et jects in Research at the University of Manitoba. al., 1977; Pfeifer et al., 1979; Prince et al., 1981; Two subjects withdrew from the study before its Renton et al., 1981; Zarowitz et al., 1981). It has completion. One withdrew due to a rash which also been reported that renal clearance of enpro- we attributed to amoxycillin. The other with- fylline is impaired by concurrent ingestion of drew when he developed otitis media prior to probenecid (Borga et al., 1986). It is probable antibiotic treatment. Demographic characteristics that enprofylline and antibiotics will be pre- are presented in Table 1 for the thirty subjects scribed together. Therefore, the study described who completed the investigation. All subjects below was undertaken to determine whether had not smoked for at least 3 months, and twenty- Correspondence: Dr Daniel S. Sitar, Clinical Pharmacology Section, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba R3E 0W3, Canada 57 58 Daniel S. Sitar et al. Table 1 Characteristics of young male volunteers for each of the three groups in the study Age Height Weight Treatment group (years) (cm) (kg) Enprofylline/amoxycillin 26 ± 4 174 ± 8 74.4 ± 10.0 Enprofylline/erythromycin 26 ± 3 173 ± 9 68.7 ± 9.8 Theophylline/erythromycin 24 ± 3 181 ± 6 74.7 ± 7.4 There were 10 subjects in each group. Data are presented as means ± s.d. five of them had never smoked. Good health was In order to assess compliance, blood samples confirmed by history, physical examination and were taken into heparinized tubes on the mornings the following tests: haemoglobin, total white of days 3 and 8 prior to ingestion of the first daily blood cell and platelet concentration, serum dose of antibiotic and a predose urine specimen albumin, total protein, lactic acid dehydrogenase, was requested on day 10 of antibiotic treatment glutamateoxaloacetate transaminase, alkaline prior to the xanthine infusion. As well, residual phosphatase, creatinine and bilirubin concen- drug doses were counted on the morning of day trations, and urinalysis and 24 h creatinine 10 of antibiotic ingestion. The urine specimens clearance. were frozen until assayed for antibiotic concen- Subjects who had ingested any drug during the tration. week preceding the first study day or who had Blood samples (14 ml) were taken from an a known hypersensitivity to xanthines, erythro- indwelling intravenous cannula in the opposite mycin, penicillins or cephalosporins were ex- forearm to the infusion site after discarding the cluded. No alcohol ingestion was allowed within first 3 ml portion. The cannula was kept patent 72 h of the first study day or throughout the with heparin in saline (10 u ml-). Samples were study. taken just before infusion (t = 0), at tho end of The study was an open parallel design with the infusion (20 min), and hourly thereafter until three groups of equal size (10 subjects per group), 6 h after the start of infusion for enprofylline, enprofylline plus amoxycillin, enprofylline plus and until 8 h after the start of the infusion for erythromycin, and theophylline plus erythro- theophylline. The samples were split into equal mycin. Baseline pharmacokinetics of theophyl- portions, half of which was placed in a tube line (10 subjects) (aminophylline, Squibb Canada containing heparin and the remainder into a Inc, 5 mg kg-1 as theophylline) or enprofylline tube containing potassium oxalate. Plasma was (20 subjects) (AB Draco, 1.5 mg kg-') were separated by centrifugation, frozen and stored at determined after a 20 min intravenous drug -20° C until analysed for drug content. Com- infusion. This test was performed either 1 week plete urine collections were taken from the sub- before antibiotic treatment or 1 week after dis- jects administered enprofylline in 2 h aliquots continuation of antibiotic treatment. Equal for drug analysis to determine its renal clearance. numbers of subjects were randomly assigned to All subjects were asked to void just before each both tim.e periods to avoid an order effect. In intravenous dose. Aliquots of all urine specimens those subjects receiving enprofylline as the test were frozen at -20° C until analysed for drug xanthine, antibiotic treatment was randomly concentration. assigned so that half of the subjects ingested Plasma samples were analysed for enprofylline amoxycillin 250 mg (Ayerst Laboratories) four and theophylline and urine samples were analysed times daily and the remainder ingested erythro- for enprofylline by high pressure liquid chroma- mycin base 250 mg (Abbott Laboratories) four tography (Borga et al., 1983). The lower limit of times daily. All subjects receiving theophylline detection for enprofylline and theophylline was as the test xanthine ingested erythromycin base 0.05 mg l-1. Assay reproducibility is indicated 250 mg four times daily as the antibiotic treat- by the following coefficients of variation: 5.0% ment. On the morning of the tenth day of anti- for 2.0 mg I-1 and 13.0% for 0.5 mg I-1 enprofyl- biotic ingestion, subjects received an intravenous line in plasma (n = 49), 5.5% for 200 mg 1-1 and infusion of their allocated xanthine to determine 11.5% for 50 mg 1-1 enprofylline in urine (n = its pharmacokinetic disposition. Antibiotic doses 8), and 3.8% for 8.0 mg I-1 and 5.1% for 4.0 mg were continued until the end of the kinetic study 1-1 theophylline in plasma (n = 21). Plasma and on the tenth day. urine samples were analysed for erythromycin Antibiotics and xanthine disposition 59 and amoxycillin by a bioassay method with B. four or eight out of a total of40 prescribed doses. subtilis as the microorganism (Grove & Randall, Over the 6 h study period for enprofylline dis- 1955; Arret et al., 1971). The lower limit of position, 4.5 ± 2.6% of a dose of erythromycin detection for the bioassays was 0.5 mg 1-1 for and 68 ± 14% of a dose of amoxycillin were both antibiotics. excreted in the urine. Erythromycin and amoxy- The kinetic disposition of enprofylline and cillin were not detected prior to the morning theophylline was determined by a model in- dose in the plasma of all subjects on days 3 and 8 dependent method. The terminal elimination of antibiotic treatment, but were present in the rate constant (Xi) was determined by least predose urine of all subjects able to void on the squares regression of the logarithm of plasma morning of the tenth day of antibiotic treatment. drug concentration vs time. Area under the Kinetic constants for enprofylline and theo- plasma concentration vs time curve (AUC) was phylline disposition in the presence and absence determined by the trapezoidal method. Residual of antibiotics are presented in Table 3. There area to infinity was determined by dividing the was no effect of either antibiotic treatment on last measured plasma drug concentration by enprofylline disposition, and the decreased renal XA. Plasma clearance (CLp) was calculated by clearance of enprofylline in the presence of dividing drug dose by AUC. Apparent volume amoxycillin only approached statistical signifi- of distribution (Varea) was calculated as CLp cance (P = 0.15). Although renal clearance of divided by Xz. Renal drug clearance (CLR) of this drug was high, it was less than plasma clear- enprofylline was calculated as amount of un- ance for all study days and for subjects in both changed drug in urine from 0 to 6 h divided by groups receiving enprofylline (P < 0.01). The the AUC for the same time period (Greenblatt effect of erythromycin on theophylline clearance & Koch-Weser, 1975). approached significance (P < 0.10). We found a Data are tested for significant differences by highly variable effect of erythromycin on theo- analysis of variance or by paired t-tests where phylline clearance (-23 to +36%; 11 ± 16%). appropriate. Data are presented as means ± s.d. No other kinetic constants for theophylline dis- A P value - 0.05 with two-tailed analysis was position were affected by erythromycin treat- considered significant, excepting comparisons ment.
Load more

Recommended publications
  • Effect of Aminophylline on Diaphragmatic Contractility in the Piglet
    003 1-3998/90/2803-0196$02.00/0 PEDIATRIC RESEARCH Vol. 28, No. 3, 1990 Copyright 0 1990 International Pediatric Research Foundation, Inc. Printed in (I.S.A. Effect of Aminophylline on Diaphragmatic Contractility in the Piglet DENNIS E. MAYOCK, THOMAS A. STANDAERT, JON F. WATCHKO, AND DAVID E. WOODRUM1 University of Washington School of Medicine, Department of Pediatrics, Division of Neonatal and Respiratory Diseases, Seattle, Washington 98195 ABSTRACT. Minute ventilation, arterial blood gases, ar- of arterial oxygen > 8 kPa (60 torr) in room air, and a partial terial pH, cardiac output, and transdiaphragmatic force pressure of the arterial carbon dioxide 5 6.7 kPa (50 torr) were generation, both during spontaneous ventilation and in accepted for study. The animals were anesthetized with an i.v. response to phrenic nerve stiwulation during airway occlu- combination of chloralose (30 mg/kg) and urethane (1 50 mg/ sion at end expiration, were measured in nine anesthetized, kg) and studied in the supine position. Subsequent infusions of tracheostomized piglets before and 30 min after parenteral anesthetic were used if the piglet developed jaw clonus. A trache- infusion of 20 mg/kg aminophylline. Serum theophylline ostomy was placed and connected to a two-way nonrebreathing levels averaged 109 f 21 ~mol/L(19.7 f 3.7 ~g/mL)at valve (model 2384, Hans Rudolph, Inc., Kansas City, MO). 30 min postinfusion. No significant changes were noted in Inspiratory flow was detected by a hot-wire anemometer and pH, blood gases, blood Pressure, or ventilatory measures integrated to provide tidal volume. All animals breathed 50% after aminophylline.
    [Show full text]
  • Aminophylline Catalog Number A1755 Storage
    Aminophylline Catalog Number A1755 Storage Temperature –20 °C Replacement for Catalog Number 216895 CAS RN 317-34-0 Storage/Stability Synonyms: theophylline hemiethylenediamine complex; Aminophylline should be kept tightly closed to prevent 3,7-dihydro-1,3-demethyl-1H-purine-2,6-dione CO2 absorption from the atmosphere, which leads to compound with 1,2-ethanediamine (2:1); formation of theophylline and decreased solubility in 1,2 3 (theophylline)2 • ethylenediamine aqueous solutions. Stock solutions should be protected from light and prevented from contact with Product Description metals.2 Molecular Formula: C7H8N4O2 ·1/2 (C2H8N2) Molecular Weight: 210.3 References 1. The Merck Index, 12th ed., Entry# 485. Aminophylline is a xanthine derivative which is a 2. Martindale: The Extra Pharmacopoeia, 31st ed., combination of theophylline and ethylenediamine that is Reynolds, J. E. F., ed., Royal Pharmaceutical more water soluble than theophylline alone. Society (London, England: 1996), pp. 1651-1652. Aminophylline has been widely used as an inhibitor of 3. Data for Biochemical Research, 3rd ed., Dawson, cAMP phosphodiesterase.3 R. M. C., et al., Oxford University Press (New York, NY: 1986), pp. 316-317. Aminophylline has been shown to limit 4. Pelech, S. L., et al., cAMP analogues inhibit phosphatidylcholine biosynthesis in cultured rat phosphatidylcholine biosynthesis in cultured rat hepatocytes.4 It has been used in studies of acute hepatocytes. J. Biol. Chem., 256(16), 8283-8286 hypoxemia in newborn and older guinea pigs.5 The (1981). effect of various xanthine derivatives, including 5. Crisanti, K. C., and Fewell, J. E., Aminophylline aminophylline, on activation of the cystic fibrosis alters the core temperature response to acute transmembrane conductance regulator (CFTR) chloride hypoxemia in newborn and older guinea pigs.
    [Show full text]
  • Rosemary)-Derived Ingredients As Used in Cosmetics
    Safety Assessment of Rosmarinus Officinalis (Rosemary)-Derived Ingredients as Used in Cosmetics Status: Tentative Amended Report for Public Comment Release Date: March 28, 2014 Panel Meeting Date: June 9-10, 2014 All interested persons are provided 60 days from the above release date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Director, Dr. Lillian J. Gill. The 2014 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This safety assessment was prepared by Monice M. Fiume, Assistant Director/Senior Scientific Analyst. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200♢ Washington, DC 20036 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢ [email protected] TABLE OF CONTENTS Abstract ......................................................................................................................................................................................................................................
    [Show full text]
  • Effect of Theophylline and Enprofylline on Bronchial Hyperresponsiveness
    Thorax: first published as 10.1136/thx.44.12.1022 on 1 December 1989. Downloaded from Thorax 1989;44:1022-1026 Effect of theophylline and enprofylline on bronchial hyperresponsiveness G H KOETER, J KRAAN, M BOORSMA, J H G JONKMAN, TH W VAN DER MARK From the Department ofPulmonology and Lung Function, University Hospital, Groningen; Pharma Bio Research, Assen; and Astra Pharmaceutica, Rijswijk, The Netherlands ABSTRACT The effect of increasing intravenous doses of theophylline and enprofylline, a new xanthine derivative, on bronchial responsiveness to methacholine was studied in eight asthmatic patients. Methacholine provocations were carried out on three days before and after increasing doses of theophylline, enprofylline, and placebo, a double blind study design being used. Methacholine responsiveness was determined as the provocative concentration of methacholine causing a fall of 20% in FEV, (PC20). The patients were characterised pharmacokinetically before the main study to provide an individual dosage scheme for each patient that would provide rapid steady state plasma concentration plateaus of 5, 10, and 15 mg/l for theophylline and 1 25, 2 5, and 3-75 mg/l for enprofylline. Dose increments in the main study were given at 90 minute intervals. FEV, showed a small progressive decrease after placebo; it remained high in relation to placebo after both drugs and this effect was dose related. Methacholine PC20 values decreased after placebo; mean values were (maximum difference 2-0 and 1 7 higher after theophylline and enprofylline than after placebo copyright. doubling doses of methacholine); the effect of both drugs was dose related. Thus enprofylline and theophylline when given intravenously cause a small dose related increase in FEV1 and methacholine PC20 when compared with placebo.
    [Show full text]
  • Download Product Insert (PDF)
    PRODUCT INFORMATION Proxyphylline Item No. 20937 CAS Registry No.: 603-00-9 Formal Name: 3,7-dihydro-7-(2-hydroxypropyl)-1,3- N dimethyl-1H-purine-2,6-dione O N Synonym: NSC 163343 C H N O MF: 10 14 4 3 N FW: 238.2 N Purity: ≥98% O UV/Vis.: λmax: 273, 324 nm Supplied as: A crystalline solid OH Storage: -20°C Stability: As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly Laboratory Procedures Proxyphylline is supplied as a crystalline solid. A stock solution may be made by dissolving the proxyphylline in the solvent of choice. Proxyphylline is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF), which should be purged with an inert gas. The solubility of proxyphylline in ethanol is approximately 1 mg/ml and approximately 10 mg/ml in DMSO and DMF. Further dilutions of the stock solution into aqueous buffers or isotonic saline should be made prior to performing biological experiments. Ensure that the residual amount of organic solvent is insignificant, since organic solvents may have physiological effects at low concentrations. Organic solvent-free aqueous solutions of proxyphylline can be prepared by directly dissolving the crystalline solid in aqueous buffers. The solubility of proxyphylline in PBS, pH 7.2, is approximately 1 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.1 It has also been reported 2 to have vasodilatory and cardiac stimulatory effects.
    [Show full text]
  • Caffeine Versus Aminophylline for Apnea of Prematurity: a Randomized Clinical Trial
    World Journal of Peri & Neonatology Vol. 2, No. 2, Fall 2019 Original Article http://wjpn.ssu.ac.ir Caffeine versus Aminophylline for Apnea of Prematurity: A Randomized Clinical Trial Mohamad Hosein Lookzadeh 1,2, Elaha Jafari-Abeshoori 2*, Mahmood Noorishadkam 1,2, Seyed Reza Mirjalili 1,2, Hamid Reza Mohammadi 3, Fatemeh Emambakhshsani 2 1 Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 2 Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 3 Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Received: 04 April 2020 Revised: 16 June 2020 Accepted: 20 July 2020 ARTICLE INFO ABSTRACT Corresponding author: Background: Apnea of prematurity is often found in preterm neonates Elaha Jafari-Abeshoori with gestational age less than 34-37 weeks or birth weight (BW) less than 1000 grams. The American Academy of Pediatrics defines apnea as a Email: [email protected] respiratory halt lasting at least 20 seconds, with bradycardia or cyanosis. Methylxanthines reduce the incidence of apnea. The purpose of this study Keywords: was to compare the effect of caffeine and aminophylline on the incidence Aminophylline, of the apnea in premature infants. Caffeine, Methods: This randomized clinical trial study was conducted on 80 Apnea, premature neonates at Shahid Sadoughi hospital in Yazd. The first group Prematurity received the initial dose of 5 mg/kg aminophylline diluted in 5% dextrose with a maintenance dose of 2 mg/kg every 8 hours, while the second group received 30 mg/kg of caffeine diluted in 5% dextrose with a 24-hour maintenance dose of 10 mg/kg.
    [Show full text]
  • Vitamin B6 Metabolism and Regulation of Pyridoxal Kinase
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2009 VITAMIN B6 METABOLISM AND REGULATION OF PYRIDOXAL KINASE Amit Gandhi Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Chemicals and Drugs Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2008 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Amit K. Gandhi 2009 All Rights Reserved VITAMIN B 6 METABOLISM AND REGULATION OF PYRIDOXAL KINASE A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. By AMIT K. GANDHI M.S (Pharmaceutical Science), Rajiv Gandhi University, Indore, India, 2003 B.Pharm, Rajiv Gandhi University, Indore, India, 2001 Director: Martin K. Safo, Ph.D Assistant Professor, Department of Medicinal Chemistry Virginia Commonwealth University Richmond, Virginia December, 2009 Acknowledgement I would like to take this opportunity to express my deep gratitude and profound respect to my advisor, Dr. Martin K. Safo, for his supervision, advice, and guidance in this research work. His support and insight have been invaluable in the progression of my research. I also appreciate his words of encouragement, which kept me always in an innovative mood and guided me at all the times to bring about the best in me. He is my mentor and teacher whom I shall remember forever.
    [Show full text]
  • The Xanthines (Theobromine and Aminophyllin)
    effect of this might conceivably escape detection in THE XANTHINES (THEOBROMINE AND individuals engaged in very heavy work. From this AMINOPHYLLINE) IN THE TREAT- point of view our subjects were particularly favorable for this since of as MENT OF CARDIAC PAIN study, most them, shown in the table, were not engaged in any occupation. HARRY M.D. GOLD, GLYCERYL TRINITRATE TEST NATHANIEL T. M.D. KWIT, Early in the course of the study it was believed AND desirable to HAROLD M.D. restrict the selection of patients to those OTTO, who could establish their qualifications for service in NEW YORK such a study as this by their ability to distinguish An endeavor was made in this study to secure evi- between the efficacy of glyceryl trinitrate taken under dence on the question of whether the xanthines relieve the tongue and a soluble placebo tablet taken in the cardiac pain. same manner for relief during attacks of pain. The SELECTION OF PATIENTS discovery of several patients who found the two equally effective those who had suffered an of The were 100 ambulant in attend- among attack subjects patients thrombosis and were to thoracic ance at the cardiac in whom the of coronary subject pain clinic, diagnosis on effort led us to abandon this restriction. arteriosclerotic heart disease with cardiac pain was made, in accordance with the nomenclature and criteria The results obtained in sixty patients in whom the the New York Heart Association.1 glyceryl trinitrate test was made are of some interest. adopted by These received trinitrate were selected from a total case load of patients glyceryl tablets, %0o They approxi- or cr 0.4 which were mately 700 patients, representing an average sample /4so grain (0.6 mg.), they of the cardiac clinic several racial directed to take under the tongue at the onset of an population, comprising attack of In of these of groups, both native and born.
    [Show full text]
  • Evaluation of Bitter Kola Leaf Extract As an Anticorrosion Additive for Mild
    RESEARCH ARTICLE V.C. Anadebe, P.C. Nnaji, N.A. Okafor, J.O. Ezeugo, F.E. Abeng and O.D. Onukwuli, 6 S. Afr. J. Chem., 2021, 75, 6–17, <https://journals.co.za/content/journal/chem/>. Evaluation of Bitter Kola Leaf Extract as an Anticorrosion Additive for Mild Steel in 1.2 M H2SO4 Electrolyte Valentine Chikaodili Anadebea,* §, Patrick Chukwudi Nnajib, Nkechinyere Amaka Okaforc, Joseph Okechukwu Ezeugoc, Fidelis Ebunta Abengd and Okechukwu Dominic Onukwulie aDepartment of Chemical Engineering, Federal University Ndufu Alike, Ebonyi State, Nigeria. bDepartment of Chemical Engineering, Michael Okpara University of Agriculture, Abia State, Nigeria. cDepartment of Chemical Engineering, Chukwuemeka Odumegwu Ojukwu University, Nigeria. dMaterial and Electrochemistry Unit, Department. of Chemistry, Cross River University of Technology, Calabar, Nigeria. eDepartment of Chemical Engineering, Nnamdi Azikwe University Awka, Anambra State, Nigeria. Received 24 January 2020, revised 29 August 2020, accepted 29 August 2020. ABSTRACT Plant-based material, namely bitter kola leaf, as an additive for surface modification of mild steel in H2SO4 solution was thoroughly scrutinized using electrochemical, theoretical and optimization techniques. The functional groups, of the biomolecules of the bitter kola leaf extract, were examined using Fourier transform infrared spectrometry (FTIR) and gas chroma- tography-mass spectrophotometry (GC-MS). For clarification purpose, scanning electron microscopy (SEM) was used to inspect the texture of the degraded and inhibited steel after 21 h of immersion. For the response surface methodology (RSM), central composite design of Design-Expert Software was used to optimize the inhibition efficiency as a function of acid concentration, inhibitor concentration, temperature and time. The optimum inhibition efficiency of 93 % was obtained at 0.9 g L–1 bitter kola leaf.
    [Show full text]
  • Introduction: P2 Receptors
    Current Topics in Medicinal Chemistry 2004, 4, 793-803 793 Introduction: P2 Receptors Geoffrey Burnstock* Autonomic Neuroscience Institute, Royal Free and University College, London NW3 2PF, U.K. Abstract: The current status of ligand gated ion channel P2X and G protein-coupled P2Y receptor subtypes is described. This is followed by a summary of what is known of the distribution and roles of these receptor subtypes. Potential therapeutic targets of purinoceptors are considered, including those involved in cardiovascular, nervous, respiratory, urinogenital, gastrointestinal, musculo-skeletal and special sensory diseases, as well as inflammation, cancer and diabetes. Lastly, there are some speculations about future developments in the purinergic signalling field. HISTORICAL BACKGROUND It is widely recognised that purinergic signalling is a primitive system [19] involved in many non-neuronal as well The first paper describing the potent actions of adenine as neuronal mechanisms and in both short-term and long- compounds was published by Drury & Szent-Györgyi in term (trophic) events [20], including exocrine and endocrine 1929 [1]. Many years later, ATP was proposed as the secretion, immune responses, inflammation, pain, platelet transmitter responsible for non-adrenergic, non-cholinergic aggregation, endothelial-mediated vasodilatation, cell proli- transmission in the gut and bladder and the term ‘purinergic’ feration and death [8, 21-23]. introduced by Burnstock [2]. Early resistance to this concept appeared to stem from the fact that ATP was recognized first P2X Receptors for its important intracellular roles and the intuitive feeling was that such a ubiquitous and simple compound was Members of the existing family of ionotropic P2X1-7 unlikely to be utilized as an extracellular messenger.
    [Show full text]
  • Intravenous Aminophylline Treatment for Migraine
    Original Observations and Research Personal Observation: Intravenous Aminophylline Treatment for Migraine Michael Kenyon MD, Barry Phillips MD, Christiaan DeWit MBBCh About the Authors Michael Kenyon (near right) and Barry Phillips (far right) are internists, and Christiaan De Wit is an emergency room physician, all practising at Mills Memorial Hospital, in Terrace, British Columbia. Correspondence may be directed to: [email protected] igraine is common condition, often affecting young inhibitor and adenosine antagonist. It has been shown in Mpatients and causing disruption in the home and dipyridamole (Persantine) MIBI studies that dipyridamole workplace alike. The impact of patients presenting to administration inhibits adenosine deaminase in red-cell emergency room services with intractable headache is membranes, increasing blood levels of adenosine. This induces significant, often tying up space and resources in the tedious coronary vasodilation through a low-affinity interaction with wait for a narcotic and sedative “cure.” In Canada alone, 3.2 the A2a receptor. The antidote, aminophylline, preferentially million adults suffer from migraines, and the condition costs binds to this receptor, displacing adenosine and curtailing its the Canadian economy an estimated $500 million annually. effect. 3,4 Absenteeism and loss of productivity resulting from migraines Aminophylline has traditionally and principally been used cost $20 every second. 1 as an intravenously or orally administered bronchodilator in Mills Memorial Hospital is a regional referral centre in asthmatics. Caution in its use should be observed in patients Terrace, British Columbia, serving a population of 70,000 with active peptic ulceration, a low seizure threshold, people. Between June 2011 and January 2012, 21 patients came hypokalemia, tachyarrhythmias, and acute congestive heart to the emergency room (ER) suffering from symptoms failure (CHF).
    [Show full text]
  • Adenosine Receptors and Endothelial Cell Mediated Wound Healing
    Adenosine Receptors And Endothelial Cell Mediated Wound Healing Author Bonyanian, Zeinab Published 2017 Thesis Type Thesis (PhD Doctorate) School School of Medical Science DOI https://doi.org/10.25904/1912/1773 Copyright Statement The author owns the copyright in this thesis, unless stated otherwise. Downloaded from http://hdl.handle.net/10072/367912 Griffith Research Online https://research-repository.griffith.edu.au Adenosine Receptors And Endothelial Cell Mediated Wound Healing Zeinab Bonyanian BSc, MSc School of Medical Science Griffith Health Griffith University Submitted in fulfilment of the requirements of the degree of Doctor of Philosophy February 2017 1 STATEMENT OF ORIGINALITY This work has not previously been submitted for a degree or diploma in any university. To the best of my knowledge and belief, the thesis contains no material previously published or written by another person except where due reference is made in the thesis itself. Zeinab Bonyanian (Zina) 2 ACKNOWLEDGEMENT Firstly, I would like to express my sincere gratitude to my principal advisor, Associate Professor Roselyn Rose’Meyer, for the continuous support of my Ph.D study and related research, for her patience, motivation, and immense knowledge. Her guidance helped me during both the research and writing of this thesis. I could not imagine having a better supervisor and mentor for my Ph.D study. I would also like to acknowledge Associate Professor Joss Du Toit, my associate supervisor, and Professor David Shum for their support. I am very thankful to Dr. Janet Hussein for providing me with professional guidance and useful advice on my thesis writing. Many thanks to my friend Ms.
    [Show full text]